Article info
PDFGI cancer
Original article
SETD2 histone modifier loss in aggressive GI stromal tumours
- Correspondence to Dr Patrick Tan, Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore; gmstanp{at}duke-nus.edu.sg or Dr Richard Quek, Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore 169610, Singapore; dmorqhh{at}nccs.com.sg
Citation
SETD2 histone modifier loss in aggressive GI stromal tumours
Publication history
- Received March 2, 2015
- Revised July 31, 2015
- Accepted August 15, 2015
- First published September 3, 2015.
Online issue publication
January 10, 2017
Article Versions
- Previous version (13 December 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/